Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the electronic drug delivery systems market?
There has been a robust growth in the size of the electronic drug delivery systems market in the past few years. The market is predicated to rise from $11.15 billion in 2024 to $12.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. Factors like the increasing prevalence of chronic diseases, an aging demographic, the patient’s shift toward non-invasive delivery methods, efforts to curtail healthcare costs, advancement in clinical practices, and validation have contributed to this development in the historical period.
What will be the electronic drug delivery systems market size in the future?
The market for electronic drug delivery systems is predicted to experience accelerated growth in the upcoming years, projected to reach “$17.74 billion by 2029 with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this impressive growth estimate in the projected period include the growing emphasis on drug personalization, increasing global healthcare spending, focus on patient-centered healthcare methods, the rise of targeted therapies, supportive regulations, and upgrade in remote patient monitoring technology. Key trends to watch in this forecast period encompass the integration of artificial intelligence (AI), use of biocompatible materials and implantable devices, customization to specific therapeutic domains, advancements in regulatory standards, and partnerships between pharmaceutical and tech firms.
Get your electronic drug delivery systems market report here!
What main drivers are fueling expansion in the electronic drug delivery systems market?
The growth of the electronic drug delivery systems market is anticipated to be driven by the increasing prevalence of chronic diseases. A chronic disease is a persisting health condition or disease lasting for over one year that necessitates continuous medical care. Electronic drug delivery systems are employed to control drug dosages, making it simpler for individuals suffering from chronic illnesses to monitor their medication intake. For example, the National Library of Medicine, a US-based organization, predicted in January 2023 that by 2050, the number of US citizens aged 50 and above having at least one chronic illness would escalate to 142.66 million. Consequently, the escalating incidence of chronic diseases is expected to stimulate the market for electronic drug delivery systems.
What key areas define the segmentation of the global electronic drug delivery systems market?
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules, Other Types
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
6) By Other Types: Transdermal Drug Delivery Systems, Implantable Drug Delivery Systems, Wearable Drug Delivery Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp
Who are the dominant players expanding their reach in the electronic drug delivery systems market?
Major companies operating in the electronic drug delivery systems market include Gerresheimer AG, Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Bayer AG, Tandem Diabetes Care, United Therapeutics Corporation, F. Hoffmann-La Roche AG, Elcam Medical, Sanofi S.A., Canè SpA, FindAir, Johnson & Johnson Services Inc., Antares Pharma Inc, Abbott Laboratories, Adherium Ltd., H&T Presspart Manufacturing Ltd., HCmed Innovations Co. Ltd., Amiko Digital Health Limited, CeQur Corporation, West Pharmaceutical Services Inc., BIOCORP
How are evolving market trends shaping electronic drug delivery systems Strategies?
Technologically superior and minimally invasive methods of drug administration comprise a major trend in the electronic drug delivery system market. Top-tier companies in this market are introducing innovative systems to maintain their competitive edge. For example, in March 2022, Evonik Industries AG, a specialty chemicals company based in Germany, unveiled EUDRATEC SoluFlow, an advanced microparticle technology designed to increase the solubility of active pharmaceutical ingredients in oral medications. This new technology forms part of the company’s suite of oral drug delivery solutions aimed at managing conditions such as cancer, cardiovascular diseases, infectious diseases, and diabetes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10734
Which regions are emerging as leaders in the electronic drug delivery systems market?
North America was the largest region in the electronic drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Drugs For Hormonal Replacement Therapy Global Market Report 2024
Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
